Results 121 to 130 of about 2,703,993 (269)

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

FEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille   +3 more
wiley   +1 more source

Adolescent Cannabis Expectancies Are Associated With Parental Drug Use History Via Negative Urgency. [PDF]

J Stud Alcohol Drugs
Azarmehr R, Geier C, Oshri A.
europepmc   +1 more source

The therapeutic opportunities and pitfalls of using iron ion chelators to treat neurodegenerative diseases

FEBS Letters, EarlyView.
Although too much iron in the brain promotes neurodegeneration, iron ion chelators have had mixed effects in clinical trials. This review explains why; some chelators do not render the iron redox‐inactive (e.g., L1) whereas others do (e.g., desferrioxamine).
Barry Halliwell
wiley   +1 more source

Long-Term Outcomes With Class 1C Antiarrhythmic Drug Use in Atrial Fibrillation. [PDF]

J Am Heart Assoc
Bhonsale A, Wang Y, Thoma F, Kancharla K, Voigt A, Shalaby A, Naniwadekar A, Singla V, Estes NA, Saba S, Mulukutla S, Jain S.   +11 more
europepmc   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

FEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg, Martine Hjeltnes, Josephine Krieger, Joshua E. Elias, Maria Stensland, Kristian Holm, Xiaojun Jiang, Chuki Khangsar, Tuula A. Nyman, Arthur Kaser, Johannes R. Hov, Tom H. Karlsen, Nicole C. Kaneider, Frode L. Jahnsen, Georg Schneditz   +14 more
wiley   +1 more source

Distinguishing a drug use disorder from drug use in a high-risk sample of youth: A random forest classification and explanatory analysis. [PDF]

Drug Alcohol Depend Rep
Berny LM, Guha A, Tanner-Smith EE.
europepmc   +1 more source

Structure‐forward targeting of claudins with synthetic binders

FEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Trends in Antipsychotic Drug Use in the United States, 2000-2016. [PDF]

Pharmacy (Basel)
Haddad N, Farhat N, Go J, Chen Y, Gravel CA, Momoli F, Mattison DR, McNair D, Alami A, Krewski D.   +9 more
europepmc   +1 more source

Discerning protein pools by selective staining with self‐labeling tags

FEBS Letters, EarlyView.
Cell surface proteins have an intra‐ and extracellular pool. Combining genetic fusion to self‐labeling tags that can be addressed with small molecule fluorophores allows separating these pools. We highlight recent developments and techniques for state‐of‐the‐art interrogation of cell surface proteins in the complex tissue setting.
Kati Fischermanns, Johannes Broichhagen
wiley   +1 more source

The Impact of MOUD Initiation in Patients With Injection Drug Use-Associated Infective Endocarditis. [PDF]

Open Forum Infect Dis
Losiewicz S, Collis B, El-Dalati S, Hall E, Cao C, Johnson M, Kobayashi T, Stoner BJ, Weaver D.   +8 more
europepmc   +1 more source